{"certainAgreement":{"piSponsorEmployee":true,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"Low accrual and early termination limits the conclusions one could draw. Although no pts on this trial met the primary endpoint of a 25% or greater M-protein reduction, the small number of pts enrolled prohibits formal statistical analysis."},"pointOfContact":{"email":"zonderj@karmanos.org","organization":"Barbara Ann Karmanos Cancer Institute","phone":"313-576-8732","title":"Jeffrey Zonder, M.D."}}